Cigarette Smoking-Induced MicroRNA Dysregulation: From Molecular Mechanisms to Systemic Disease Networks and Therapeutic Implications
International Journal of Medical Toxicology and Forensic Medicine · 22.08.2026
DOI: 10.22037/ijmtfm.v16.52813 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Toxicology and Forensic Medicine, erschienen am 22.08.2026. Verfasst von Seyed Hosein Moosavipanah und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Background
MicroRNAs (miRNAs) are small non‑coding transcripts that regulate gene expression and modulate diverse cellular processes, including proliferation, apoptosis, and immune responses. Cigarette smoking (CS) remains the leading preventable cause of global morbidity and mortality, with tobacco smoke comprising over 7,000 chemicals that inflict cellular damage through oxidative stress, DNA adduction, and epigenetic reprogramming. Accumulating evidence has established miRNAs as critical mediators of CS‑induced pathogenesis, with miRNA dysregulation now recognized as a fundamental mechanism linking smoking to a wide spectrum of human diseases. This review synthesizes current knowledge on the roles of miRNAs in smoking‑related malignancies, chronic respiratory diseases, cardiovascular disorders, psychiatric illnesses, dermatological conditions, and gastrointestinal diseases. Materials and Methods: This narrative review searched PubMed, Web of Science, Scopus, and ScienceDirect (2007–2025). Seventy-three eligible studies on miRNA dysregulation in smoking-related diseases were qualitatively synthesized to assess molecular mechanisms and clinical potential.
Results
The Rotterdam Study identified 41 circulating smoking-related miRNAs, 38 of which reversed after cessation. Cigarette smoke alters miRNA pathways involved in angiogenesis, COPD, inflammatory bowel disease, psychiatric disorders, and skin aging. These miRNA profiles may support non-invasive risk stratification, diagnosis, and treatment monitoring, although further validation and standardization are required.
Conclusion
This review integrates epidemiological, experimental, and clinical findings to provide a comprehensive framework for understanding smoking‑induced miRNome remodeling and its contribution to disease burden, while identifying critical knowledge gaps for future research.
Schlagwörter
Zitieren
APA
Moosavipanah, S. H., Molavi, N., Hashemian, S., Moghadam, H. R., Farahzadi, M., Mehrzad, F., Saffari, I., Abbaszadeh‐Mashkani, S., Damyar, M. A., Sarollahi, R., Amir, G., & Dehkohneh, S. G. (2026). Cigarette Smoking-Induced MicroRNA Dysregulation: From Molecular Mechanisms to Systemic Disease Networks and Therapeutic Implications. International Journal of Medical Toxicology and Forensic Medicine. https://doi.org/10.22037/ijmtfm.v16.52813
Vancouver
Moosavipanah SH, Molavi N, Hashemian S, Moghadam HR, Farahzadi M, Mehrzad F, et al. Cigarette Smoking-Induced MicroRNA Dysregulation: From Molecular Mechanisms to Systemic Disease Networks and Therapeutic Implications. International Journal of Medical Toxicology and Forensic Medicine. 2026. doi:10.22037/ijmtfm.v16.52813
BibTeX
@article{Moosavipanah2026,
author = {Moosavipanah, Seyed Hosein and Molavi, Nader and Hashemian, Shervin-Sadat and Moghadam, Hassan Rajabi and Farahzadi, Mohammadhadi and Mehrzad, Fateme and Saffari, Iman and Abbaszadeh‐Mashkani, Samira and Damyar, Mohammad Amin and Sarollahi, Rouhollah and Amir, Ghaderi and Dehkohneh, Somayeh Ghadami},
title = {Cigarette Smoking-Induced MicroRNA Dysregulation: From Molecular Mechanisms to Systemic Disease Networks and Therapeutic Implications},
journal = {International Journal of Medical Toxicology and Forensic Medicine},
year = {2026},
doi = {10.22037/ijmtfm.v16.52813}
}
EUVIMED